Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information on how we use and manage cookies please take a look at our privacy and cookie policies. Some parts of the site may not work properly if you choose not to accept cookies.

sections
Home > Actiance, Inc. > Social Media Risks and Benefits for the Pharmaceutical Industry
 

Social Media Risks and Benefits for the Pharmaceutical Industry

White Paper Published By: Actiance, Inc.
Actiance, Inc.
Published:  Jan 15, 2015
Type:  White Paper
Length:  22 pages

Social Media Risks and Benefits for the Pharmaceuticals Industry
Drug makers are just beginning to realize how social networks can improve business processes. Social media helps your organization share information and exchange ideas with your customers quickly, but doing so can involve considerable risk. Thatís because social media is subject to the scrutiny of regulators, legislators, and litigators. So, what seems like a spoon full of sugar is often a tough pill to swallow when you consider regulatory requirements from agencies like the FDA. On top of that, increasing litigation has made it a business requirement to consider solutions that help bring down skyrocketing legal costs. Not having technology in place to help manage these requirements and increasing risks, or doing so without careful planning, can be a costly mistake.

Read this paper to gain an understanding of:

  • What the regulatory landscape of the pharmaceuticals industry looks like
  • What concerns you should be aware of from a legal perspective



Tags : 
social media, increased risks, business processes, regulatory requirements, it management